FDA Expands Requirements for New Drug Applications and Clinical Study Enrollment

Summary

The FDA is updating its regulations to require drug manufacturers to report demographic data on clinical study enrollment, including age, gender, and racial groups, to ensure more accurate and diverse trial results.